Specific protein degradation by copper(II) ions.
Allen
G
G
D000074323:Alemtuzumab; D000818:Animals; D000911:Antibodies, Monoclonal / Q000187:drug effects / Q000378:metabolism; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000187:drug effects / Q000378:metabolism; D001665:Binding Sites; D002021:Buffers; D002412:Cations / Q000737:chemistry / Q000494:pharmacology; D002417:Cattle; D003300:Copper / Q000737:chemistry / Q000494:pharmacology*; D006639:Histidine / Q000737:chemistry; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D007128:Immunoglobulin Fragments / Q000737:chemistry / Q000187:drug effects; D007074:Immunoglobulin G / Q000187:drug effects / Q000378:metabolism; D007700:Kinetics; D015394:Molecular Structure; D010084:Oxidation-Reduction; D010446:Peptide Fragments / Q000737:chemistry / Q000187:drug effects; D011485:Protein Binding; D011487:Protein Conformation; D011506:Proteins / Q000737:chemistry / Q000187:drug effects*; D013379:Substrate Specificity
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D002021:Buffers; D002412:Cations; D007128:Immunoglobulin Fragments; D007074:Immunoglobulin G; D010446:Peptide Fragments; D011506:Proteins; D000074323:Alemtuzumab; D006639:Histidine; D003300:Copper